Therapeutic drug monitoring guided raltegravir dosing for prevention of vertical transmission in a premature neonate born to a woman living with perinatally acquired HIV

被引：7

作者：

Kreutzwiser, Denise ^{[1
,2
,3
]}

Sheehan, Nancy ^{[1
,4
,5
]}

Dayneka, Natalie ^{[6
]}

Lemire, Benoit ^{[1
,4
]}

Wong, Alison ^{[1
,4
]}

Samson, Lindy ^{[6
,7
]}

Brophy, Jason ^{[6
,7
]}

机构：

[1] McGill Univ, Hlth Ctr, Chron Viral Illness Serv, Montreal, PQ, Canada

[2] Univ Hlth Network, Toronto Gen Hosp, Immunodeficiency Clin, Toronto, ON, Canada

[3] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada

[4] McGill Univ, Hlth Ctr, Quebec Antiretroviral Therapeut Drug Monitoring P, Montreal, PQ, Canada

[5] Univ Montreal, Fac Pharm, Montreal, PQ, Canada

[6] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada

[7] Univ Ottawa, Fac Med, Dept Pediat, Ottawa, ON, Canada

来源：

ANTIVIRAL THERAPY | 2017年 / 22卷 / 06期

关键词：

PHARMACOKINETICS; MOTHER;

D O I：

10.3851/IMP3139

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We report a case of therapeutic drug monitoring guided raltegravir use for the prevention of vertical HIV transmission in a premature neonate born to a woman living with perinatally acquired HIV and documented resistance to multiple HIV drugs. Maternal viral load was above 1,000 copies/ml at delivery. This case demonstrates delayed raltegravir elimination in a neonate born at 33 weeks gestational age and a need for less frequent raltegravir dosing than is used in older infants and children.

引用

页码：545 / 549

页数：5

共 14 条

[11] Nevirapine Pharmacokinetics and Safety in Neonates Receiving Combination Antiretroviral Therapy for Prevention of Vertical HIV Transmission
Lau, Elaine
Brophy, Jason
Samson, Lindy
Kakkar, Fatima
Campbell, Douglas M.
Yudin, Mark H.
Murphy, Kellie
Seto, Winnie
Colantonio, David
Read, Stanley E.
Bitnun, Ari
[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 (05) : 493 - 498
[12] Liverpool Drug Interactions Group University of Liverpool, NEV PK FACT SHEET
[13] Pharmacokinetics and Pharmacodynamics of Once-Daily versus Twice-Daily Raltegravir in Treatment-Naive HIV-Infected Patients
Rizk, Matthew L.
Hang, Yaming
Luo, Wen-Lin
Su, Jing
Zhao, Jing
Campbell, Havilland
Nguyen, Bach-Yen T.
Sklar, Peter
Eron, Joseph J., Jr.
Wenning, Larissa
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 3101 - 3106
[14] First reported use of elvitegravir and cobicistat during pregnancy
Schalkwijk, Stein
Colbers, Angela
Konopnicki, Deborah
Greupink, Rick
Russel, Frans G. M.
Burger, David
[J]. AIDS, 2016, 30 (05) : 807 - 808

← 1 2 →